← Back to Search

Behavioral Intervention

Sleep and Circadian Rhythm + Memory Support for Sleep Disorders

N/A
Recruiting
Led By Allison Harvey, PhD
Research Sponsored by University of California, Berkeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4 of treatment as well as post treatment, defined as two weeks after the final therapy session (i.e. 8-10 weeks after the initial intake interview) to 6-month follow-up to 12-month follow-up]
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if a new intervention can help improve sleep, reduce disability, and improve memory in people 50+ with mental illness.

Who is the study for?
This trial is for individuals aged 50 and older who speak English, have mobility issues, low income, and show no signs of cognitive impairment. They must be experiencing sleep or circadian disturbances but not severe untreated sleep apnea or other conditions that severely affect sleep. Participants need to consent to communication between researchers and their medical providers.
What is being tested?
The study tests a new Memory Support Intervention (MSI) designed to improve treatment outcomes by enhancing patient memory. It focuses on people with mental illness suffering from sleep disorders and aims to see if MSI can better their sleep patterns, daily functioning, and memory retention.
What are the potential side effects?
Since this is a psychological intervention focusing on improving memory support through behavioral techniques rather than medication, specific side effects are not listed like those for drug trials. However, participants may experience changes in mood or stress levels due to the nature of the therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4 of treatment as well as post treatment, defined as two weeks after the final therapy session (i.e. 8-10 weeks after the initial intake interview) to 6-month follow-up to 12-month follow-up]
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4 of treatment as well as post treatment, defined as two weeks after the final therapy session (i.e. 8-10 weeks after the initial intake interview) to 6-month follow-up to 12-month follow-up] for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient-Reported Outcomes Measurement Information System - Sleep Disturbance
Satisfaction with Life Scale
Sheehan Disability Scale
Secondary study objectives
Adapted Utilization Scale
Cognitive Failures Questionnaire
Composite Sleep Health Score
+20 more
Other study objectives
Adapted Brief Disability Questionnaire
Adapted Credibility Expectancy Questionnaire
Adverse events checklist
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TranS-C+MSIExperimental Treatment2 Interventions
Transdiagnostic Intervention for Sleep and Circadian Dysfunction will be combined with the Memory Support Intervention
Group II: TranS-C aloneActive Control1 Intervention
The Transdiagnostic Sleep and Circadian Intervention will be delivered alone
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transdiagnostic Intervention for Sleep and Circadian Dysfunction
2015
N/A
~130

Find a Location

Who is running the clinical trial?

University of California, BerkeleyLead Sponsor
186 Previous Clinical Trials
640,570 Total Patients Enrolled
Allison Harvey, PhDPrincipal InvestigatorUniversity of California, Berkeley
9 Previous Clinical Trials
1,753 Total Patients Enrolled

Media Library

Memory Support Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05986604 — N/A
Sleep Disorders Research Study Groups: TranS-C+MSI, TranS-C alone
Sleep Disorders Clinical Trial 2023: Memory Support Intervention Highlights & Side Effects. Trial Name: NCT05986604 — N/A
Memory Support Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05986604 — N/A
~119 spots leftby Feb 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top